ClinicalTrials.gg
CompletedNCT00522860Updated Jan 12, 2012

A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery

A Phase 4 interventional study of Trichiasis surgery with absorbable sutures and Trichiasis surgery with non-absorbable sutures in Trachomatous Trichiasis and Trachoma, sponsored by London School of Hygiene and Tropical Medicine. Completed at 1 site in Ethiopia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-01-12.

Sponsored by London School of Hygiene and Tropical Medicine · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
1,300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Trachoma is the leading infectious cause of blindness worldwide. Recurrent infection by Chlamydia trachomatis causes in-turning of the eyelids / lashes (trichiasis), leading to corneal damage and blindness. The WHO recommends corrective eyelid surgery for trichiasis. Unfortunately, trichiasis frequently returns following surgery. The purpose of this study is to compare the outcome of surgery (at one and two years) for trichiasis using two currently used alternative suture types: non-absorbable (silk) and absorbable (vicryl). We, the researchers, hypothesise that the supportive presence of the absorbable suture for a longer period produces more stable wound healing, leading to a better outcome.

Read the detailed description

Primary outcome measure:

Recurrent trichiasis, defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at one year.

Justification of primary outcome:

The aim of surgery is a permanent solution for trichiasis. If a patient has eyelashes touching the eyeball or there is clinical evidence that they are epilating to prevent this or they have required repeat trichiasis surgery, surgery can be deemed a failure.

Analysis of primary outcome measure

Intention to treat analysis of risk factors for recurrence.

Primary analysis of primary outcome:

It is expected that the important baseline characteristics (those that are known to affect the risk of recurrence) will be balanced between the two arms by stratified (for operating surgeon) randomisation. If this is found to be the case, the outcome of the surgery in the two arms will be compared in an unadjusted logistic regression model for recurrent trichiasis at one year. If the arms are found to be substantially imbalanced with respect to, pre-operative severity, gender or age, an appropriately adjusted logistic regression model will be used.

Individuals will be considered to be recurrent trichiasis cases if they have developed recurrent trichiasis at anytime during the one year follow-up period.

Secondary analysis of primary outcome:

  1. Effect modification We will assess effect modification of the intervention on recurrence at one year with the following factors by including an interaction term with treatment arm in the logistic regression model.

    1. Operating surgeon
    2. Pre-operative severity
    3. Sex
    4. Age group
    5. Conjunctival (papillary) inflammation
    6. Surgical complications
  2. Analysis of risk factors for recurrence:

    A multivariate logistic regression model will be used to identify potential explanatory factors for recurrent trichiasis at one year, in addition to the randomised suture type allocation. Other factors which will be examined in a model of recurrent trichiasis will include

    1. pre-operative disease severity

      • trichiasis
      • entropion
      • corneal opacity
    2. surgeon
    3. infection status at baseline and follow up timepoints
    4. inflammation status at baseline and follow up timepoints
    5. whether epilation is being practised
    6. sex
    7. age
    8. geographic location of patient's home
    9. literacy
    10. body mass index
    11. eye dryness

      • symptoms
      • signs
  3. Impact of intervention on time-to-first-recurrence. Kaplan-Meier analysis will be used to plot the survival curves for both treatment arms up to the final visit at 2 years. Cox regression will be used to assess the impact of the intervention on time to first recurrence. The hazard ratio will be estimated with Cox regression, adjusting for substantial baseline imbalances if appropriate.
  4. Recurrence at two years Intention-to-treat analysis will be used to assess the impact of the intervention on failure at 2 years. Failure will be defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at either one year and/or two year follow-up visits.

Secondary outcome measures

  1. Lashes touching the eyeball The effect of the intervention on the number of lashes touching at one, and two years, respectively, will be analysed using zero inflated Poisson regression (i.e. treating number of lashes as a continuous variable)
  2. Entropion grade The effect of the intervention on the degree of entropion will be analysed by ordered logistic regression
  3. Conjunctivilisation of the lid margin grade The effect of the intervention on the degree of conjunctivilisation will be analysed by ordered logistic regression
  4. Clinical evidence of epilation The effect of the intervention on clinical evidence of epilation will be assessed at one and two years respectively with logistic regression. In addition, Cox regression will be used to analyse time-to-first evidence of epilation.
  5. Repeat surgery The effect of the intervention on the proportion with repeat surgery will be assessed at one and two years respectively with logistic regression. In addition, Cox regression will be used to analyse time-to-first evidence of first repeat surgery.
  6. Recurrence (lashes touching the eyeball, clinical evidence of epilation, repeat surgery) + history of epilation A secondary definition of recurrence will incorporate self-reported history of epilation. The primary analyses will be repeated with this definition of recurrence.
  7. Corneal opacification (CO) (categorical variable)

    1. Descriptive measures of the baseline severity of CO
    2. Description of the change in CO between baseline and one and two year follow up time-points.
    3. Ordered logistic regression analysis for factors associated with change in CO at one year and two years, respectively, including to identify factors associated with it, such as suture type and inflammation.
  8. Visual acuity (VA) (categorical variable) The effect of the intervention on the visual acuity (logMAR score) at 12 and 24 months will be analysed by linear regression.
  9. Surgical complications

    Surgical complications other than recurrence, such as granuloma, incomplete lid closure, inflammation (secondary to either of the two sutures materials) and infection can occur. Descriptive statistics, with significance testing will be used to compare the rates of occurrence of all complications and individual complications at any time during the study period between the two arms of the study.

  10. Patient satisfaction

Patients are asked the following questions on the follow up questionnaires that indicate their satisfaction with the procedure:

  1. Do you think your vision is worse, the same or better than before your surgery?
  2. Do you have eye pain?
  3. If you have eye pain is it worse, the same or better than before the operation?
  4. Do your eyes water?
  5. Did you find the surgery painful?
  6. If the eyelashes have returned or will return would you seek further surgery?

The proportion answering 'yes' to each of these questions will be compared between the two arms of the trial.

Additionally the answers to questions (b) and (d) will be compared between baseline (pre-operative) and the answer given at each time point within each arm.

02

Conditions studied

  • Trachomatous Trichiasis
  • Trachoma

Browse trials for

Keywords

  • Trichiasis
  • Trachoma
  • Surgery
  • Suture
  • Ethiopia
03

In context

Trachoma

39 studies on the registry are indexed under Trachoma; 3 are open to participants now.

This study's enrollment of 1,300 is close to the median of 1,300 across 31 interventional studies indexed under Trachoma.

Browse Trachoma studies →

Lead sponsor

London School of Hygiene and Tropical Medicine is the lead sponsor of 298 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Major trichiasis: more than 5 lashes touching the eye

Exclusion criteria

Exclusion Criteria:

  • Previous eyelid surgery
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
1,300 participants (actual)

Study arms

  • Experimental
    Vicryl Suture

    Vicryl sutures, 5/0, 3/8 curved cutting needle

    Procedure: Trichiasis surgery with absorbable sutures

  • Active comparator
    Silk Suture

    Silk suture, 4/0, 3/8 curved cutting needle

    Procedure: Trichiasis surgery with non-absorbable sutures

Interventions

  • ProcedureTrichiasis surgery with absorbable sutures

    Posterior lamellar tarsal rotation. Vicryl sutures, 5/0, 3/8 curved needle, cutting. Three everting sutures.

  • ProcedureTrichiasis surgery with non-absorbable sutures

    Posterior lamellar tarsal rotation. Silk sutures. 4/0. 3/8 curved cutting needle. Three sets of everting sutures.

06

What researchers measure

Primary outcomes

  1. Recurrent trichiasis

    Recurrent trichiasis, defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at one year.

    Time frame: One and two years

Secondary outcomes

  1. Entropion

    Time frame: One and two years

  2. Corneal opacity

    Time frame: One and two years

  3. Visual Acuity Change

    Time frame: One and Two years

  4. Conjunctivilisation of the lid margin grade

    Time frame: One and two years

  5. Repeat Trichiasis Surgery

    Time frame: At any time during two years followup.

07

Study locations

1 site
  • Bahir Dar Regional Health Bureau
    Bahir Dar, Amhara, Ethiopia
08

References and documents

Publications

  • Rajak SN, Habtamu E, Weiss HA, Kello AB, Gebre T, Genet A, Bailey RL, Mabey DC, Khaw PT, Gilbert CE, Emerson PM, Burton MJ. Absorbable versus silk sutures for surgical treatment of trachomatous trichiasis in Ethiopia: a randomised controlled trial. PLoS Med. 2011 Dec;8(12):e1001137. doi: 10.1371/journal.pmed.1001137. Epub 2011 Dec 13. PubMed 22180732 ↗
  • Gower EW, Munoz B, Rajak S, Habtamu E, West SK, Merbs SL, Harding JC, Alemayehu W, Callahan EK, Emerson PM, Gebre T, Burton MJ. Pre-operative trichiatic eyelash pattern predicts post-operative trachomatous trichiasis. PLoS Negl Trop Dis. 2019 Oct 7;13(10):e0007637. doi: 10.1371/journal.pntd.0007637. eCollection 2019 Oct. PubMed 31589610 ↗
  • Rajak SN, Habtamu E, Weiss HA, Bedri A, Zerihun M, Gebre T, Gilbert CE, Emerson PM, Burton MJ. Why do people not attend for treatment for trachomatous trichiasis in Ethiopia? A study of barriers to surgery. PLoS Negl Trop Dis. 2012;6(8):e1766. doi: 10.1371/journal.pntd.0001766. Epub 2012 Aug 28. PubMed 22953007 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00522860
Responsible party
Sponsor
First posted
Aug 30, 2007
Start date
Mar 2008
Primary completion
May 2010
Completion
May 2010
Last update
Jan 12, 2012

Study contacts

Matthew J Burton, PhD FRCOphth
principal investigator · London School of Hygiene and Tropical Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion